A.R.T. Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

A.R.T. Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-27,591	Closed	-$87K	–	1919
2019 Q2	$87K	Buy	+27,591	New	+$89.5K	﹤0.01%	1212
2019 Q1	–	Sell	-36,391	Closed	-$106K	–	1813
2018 Q4	$106K	Sell	36,391 -98,319	-73%	-$270K	0.01%	1158
2018 Q3	$354K	Buy	+134,710	New	+$331K	0.02%	980
2018 Q2	–	Sell	-150,099	Closed	-$441K	–	1998
2018 Q1	$441K	Buy	+150,099	New	+$410K	0.02%	1007
2017 Q3	–	Sell	-39,109	Closed	-$96K	–	1918
2017 Q2	$96K	Sell	39,109 -331,891	-89%	-$763K	0.01%	1258
2017 Q1	$842K	Buy	371,000 +208,100	+128%	+$460K	0.04%	620
2016 Q4	$345K	Buy	+162,900	New	+$455K	0.02%	893
2016 Q3	–	Sell	-432,031	Closed	-$1.36M	–	1550
2016 Q2	$1.36M	Sell	432,031 -379,977	-47%	-$1.27M	0.07%	431
2016 Q1	$2.7M	Buy	812,008 +204,700	+34%	+$638K	0.12%	236
2015 Q4	$2.15M	Buy	607,308 +507,647	+509%	+$2.12M	0.1%	270
2015 Q3	$501K	Sell	99,661 -253,011	-72%	-$1.45M	0.02%	876
2015 Q2	$2.27M	Buy	352,672 +248,579	+239%	+$1.67M	0.08%	397
2015 Q1	$732K	Sell	104,093 -156,169	-60%	-$1.13M	0.03%	774
2014 Q4	$2.01M	Buy	260,262 +89,383	+52%	+$707K	0.07%	395
2014 Q3	$1.28M	Buy	+170,879	New	+$1.59M	0.06%	435
2013 Q4	–	Sell	-181,769	Closed	-$1.45M	–	1785
2013 Q3	$1.45M	Buy	+181,769	New	+$1.46M	0.08%	376

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

A.R.T. Advisors's PDLI Position: Q3 2019 in Review

A.R.T. Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q3 2019, closing a stake of 27,591 shares — an estimated $87K sold.

A.R.T. Advisors first reported a position in PDLI in Q3 2013 and held it in 16 quarters. The position peaked at $2.7M in Q1 2016. 140 funds tracked by Wall St. Rank hold PDLI as of Q3 2019.

A.R.T. Advisors reported no remaining PDL BioPharma, Inc. position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 27,591 PDL BioPharma, Inc. shares in Q3 2019, an estimated $87K.
A.R.T. Advisors first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 16 quarters.
A.R.T. Advisors's PDL BioPharma, Inc. position peaked at $2.7M in Q1 2016.
140 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.